<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Morbid <z:hpo ids='HP_0001513'>obesity</z:hpo> (BMI&gt;40 kg/m(2)) affecting 0.5-5% of the adult population worldwide is a major risk factor for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to elucidate the genetic bases of <z:mp ids='MP_0002055'>diabetes</z:mp> associated with <z:hpo ids='HP_0001513'>obesity</z:hpo> (diabesity), and to analyse the impact of corpulence on the effects of <z:mp ids='MP_0002055'>diabetes</z:mp> susceptibility genes </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We genotyped known single nucleotide polymorphisms (SNPs) in the adiponectin-encoding adipocyte C1q and collagen-domain-containing (ACDC) gene (-11,391G&gt;A, -11,377C&gt;G, +45T&gt;G and +276G&gt;T), the peroxisome proliferator-activated receptor gamma (PPARG) Pro12Ala SNP and ACDC exon 3 variants in 703 French morbidly <z:mp ids='MP_0001261'>obese</z:mp> subjects (BMI 47.6+/-7.4 kg/m(2)), 808 non-<z:mp ids='MP_0001261'>obese</z:mp> subjects (BMI&lt;30 kg/m(2)) and 493 <z:mp ids='MP_0001261'>obese</z:mp> subjects (30&lt; or =BMI&lt;40 kg/m(2)) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Two 5'-ACDC SNPs -11,391G&gt;A, -11,377C&gt;G were associated with adiponectin levels (p=0.0003, p=0.008) and defined a "low-level" haplotype associated with <z:mp ids='MP_0004893'>decreased adiponectin levels</z:mp> (p=0.0002) and insulin sensitivity (p=0.01) and with a risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> that was twice as high (p=0.002) </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, the prevalence of the PPARG Pro12Ala was identical in diabetic and normoglycaemic morbidly <z:mp ids='MP_0001261'>obese</z:mp> subjects </plain></SENT>
<SENT sid="5" pm="."><plain>The PPARG Pro12 allele only displayed a trend of association with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in the non-<z:mp ids='MP_0001261'>obese</z:mp> group </plain></SENT>
<SENT sid="6" pm="."><plain>ACDC exon 3 variants were associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in the non-<z:mp ids='MP_0001261'>obese</z:mp> group only (odds ratio 7.85, p&lt;0.0001) </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, the 5'-ACDC "low-level" haplotype was associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in <z:mp ids='MP_0001261'>obese</z:mp> and morbidly <z:mp ids='MP_0001261'>obese</z:mp> subjects (odds ratio 1.73 and 1.92) but not in non-<z:mp ids='MP_0001261'>obese</z:mp> individuals </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS/INTERPRETATION: These data clarify the contribution of the 5'-ACDC SNPs to the risk of diabesity </plain></SENT>
<SENT sid="9" pm="."><plain>Their interaction with corpulence suggests for the first time a different genetic profile of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in morbidly <z:mp ids='MP_0001261'>obese</z:mp> patients compared with in less <z:mp ids='MP_0001261'>obese</z:mp> individuals </plain></SENT>
</text></document>